Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Jong Lyul Ghim"'
Autor:
Jong-Lyul Ghim1,2, Sangzin Ahn2,3 sangzinahn@inje.ac.kr
Publikováno v:
Translational & Clinical Pharmacology. Sep2023, Vol. 31 Issue 3, p131-138. 8p.
Autor:
Ryunha Kim, Rannissa Puspita Jayanti, Hongyeul Lee, Hyun-Kuk Kim, Jiyeon Kang, I-Nae Park, Jehun Kim, Jee Youn Oh, Hyung Woo Kim, Heayon Lee, Jong-Lyul Ghim, Sangzin Ahn, Nguyen Phuoc Long, Yong-Soon Cho, Jae-Gook Shin, On behalf of the cPMTb
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: This study was performed to develop a population pharmacokinetic model of pyrazinamide for Korean tuberculosis (TB) patients and to explore and identify the influence of demographic and clinical factors, especially geriatric diabetes mell
Externí odkaz:
https://doaj.org/article/9eedc47a01144819b16c5366d6ddcd17
Autor:
Kyung‐Sang Yu, In‐Jin Jang, Hyeong‐Seok Lim, Jang Hee Hong, Min‐Gul Kim, Min Kyu Park, Doo‐Yeoun Cho, Min Soo Park, Jae Yong Chung, Jong‐Lyul Ghim, SeungHwan Lee, Seok Kyu Yoon, In Sun Kwon, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Jung Bin Cha, Daniel E. Furst, Edward Keystone, Jonathan Kay
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)
Abstract This study aimed to demonstrate pharmacokinetic (PK) equivalence of a single dose of the proposed adalimumab biosimilar CT‐P17 to United States‐licensed adalimumab (US‐adalimumab) and European Union‐approved adalimumab (EU‐adalimum
Externí odkaz:
https://doaj.org/article/7d507bd001904a1aa34884f6d604a326
Publikováno v:
Translational & Clinical Pharmacology; Jun2024, Vol. 32 Issue 2, p98-106, 9p
Autor:
Nguyen Thi Hai Yen, Nguyen Ky Anh, Rannissa Puspita Jayanti, Nguyen Ky Phat, Dinh Hoa Vu, Jong-Lyul Ghim, Sangzin Ahn, Jae-Gook Shin, Jee Youn Oh, Nguyen Phuoc Long, Dong Hyun Kim
Publikováno v:
Biochimie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f656b39e76f401f4deb11e190a9b46f7
https://doi.org/10.1016/j.biochi.2023.04.009
https://doi.org/10.1016/j.biochi.2023.04.009
Autor:
Yong-Soon Cho, Phuong Thi Thu Nguyen, Jong-Lyul Ghim, Jin Ah Jung, Eun Young Kim, Masud Parvez, Jae-Gook Shin, Melih O. Babaoglu, Said Kalkisim, Jeong-Kon Park
Publikováno v:
British Journal of Clinical Pharmacology. 88:1159-1169
Aim Tenofovir and para-aminosalicylic acid (PAS) may be co-prescribed to treat patients with concomitant infections of human immunodeficiency virus and Mycobacterium tuberculosis bacteria. Both drugs are known to have remarkable renal uptake transpor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98cc2234e23e7c38b0f42e9d0a6123d6
https://doi.org/10.1111/bcp.15056
https://doi.org/10.1111/bcp.15056
Autor:
Jae-Gook Shin, Young-Kyung Choi, Hyun Kyung Lee, Yumi Park, Jong-Lyul Ghim, Hyo-Jung Kim, Jee Youn Oh, Nguyen Thi Thu Phuong, Yong-Soon Cho, Hye Kyeong Park, Nguyen Phuoc Long, Tae-Won Jang
Publikováno v:
The Journal of Clinical Pharmacology. 61:1567-1578
The wide variability of isoniazid (INH) pharmacokinetics is mainly attributed to the trimodal N-acetyltransferase 2 (NAT2) acetylator phenotype, i.e., rapid, intermediate, and slow. Consequently, a uniform INH dose in the current clinical practice ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93234b48e325168d9ad1d32e456c5fdc
https://doi.org/10.1002/jcph.1931
https://doi.org/10.1002/jcph.1931
Autor:
Jung Bin Cha, Jong Lyul Ghim, Yun Ju Bae, In Sun Kwon, Hyeong Seok Lim, Sung-Hyun Kim, In-Jin Jang, Daniel E. Furst, Kyung Sang Yu, Sang Joon Lee, Jae Yong Chung, Doo-Yeoun Cho, Edward C. Keystone, Min Kyu Park, Jang Hee Hong, Min Soo Park, Jonathan Kay, Min-Gul Kim, Seung-Hwan Lee, Seok Kyu Yoon
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)
Clinical and Translational Science
Clinical and Translational Science
This study aimed to demonstrate pharmacokinetic (PK) equivalence of a single dose of the proposed adalimumab biosimilar CT‐P17 to United States‐licensed adalimumab (US‐adalimumab) and European Union‐approved adalimumab (EU‐adalimumab). This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0bf9cbad8bbb9778d884d99b5281e7
https://doaj.org/article/7d507bd001904a1aa34884f6d604a326
https://doaj.org/article/7d507bd001904a1aa34884f6d604a326
Autor:
Minkyung Oh, Heechan Lee, Seokuee Kim, Bongtae Kim, Geun Seog Song, Jae-Gook Shin, Jong-Lyul Ghim
Publikováno v:
Translational & Clinical Pharmacology; Jun2023, Vol. 31 Issue 2, p114-123, 10p
Autor:
Yazun Bashir Jarrar, Eun-Young Cha, Kyung-Ah Seo, Jong-Lyul Ghim, Hyo-Ji Kim, Dong-Hyun Kim, Su-Jun Lee, Jae-Gook Shin
Publikováno v:
Journal of Lipid Research, Vol 55, Iss 11, Pp 2334-2342 (2014)
The compound 20-HETE is involved in numerous physiological functions, including blood pressure and platelet aggregation. Glucuronidation of 20-HETE by UDP-glucuronosyltransferases (UGTs) is thought to be a primary pathway of 20-HETE elimination in hu
Externí odkaz:
https://doaj.org/article/d955e0afd3da41f9b66a74583ab6d373